Trials / Withdrawn
WithdrawnNCT02736539
Clinical Trial of CBS-2004 in Prevention of Travelers' Diarrhea
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Clasado Biosciences Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study is designed as a randomized double-blinded treatment trial among travelers' to geographical areas with moderate-severe rates of traveler's diarrhea. Travelers will be randomized to receive CBS 2004 or masked placebo to be taken daily while traveling. The test article or placebo will be taken starting 7 days prior to travel.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CBS 2004 (galacto-oligosaccharides) | CBS 2004 active treatment |
| DRUG | Placebo | Placebo treatment |
Timeline
- Start date
- 2017-04-15
- Primary completion
- 2018-12-31
- Completion
- 2019-02-28
- First posted
- 2016-04-13
- Last updated
- 2017-07-21
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02736539. Inclusion in this directory is not an endorsement.